Strategic Wealth Partners, Ltd. Biogen Inc. Transaction History

Strategic Wealth Partners, Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	SELL	$253.3 - $285.89 $112,718 - $127,221	-445 Reduced 11.65%	3,376 $867,000
Q2 2023 May 20, 2024	SELL	$275.25 - $318.06 $17,891 - $20,673	-65 Reduced 1.67%	3,821 $1.09 Million
Q1 2023 Apr 24, 2023	SELL	$256.56 - $292.34 $92,618 - $105,534	-361 Reduced 8.5%	3,886 $1.08 Million
Q4 2022 Apr 24, 2023	SELL	$252.44 - $306.72 $125,967 - $153,053	-499 Reduced 10.51%	4,247 $1.18 Million
Q3 2022 Apr 24, 2023	SELL	$194.69 - $268.46 $1.62 Million - $2.23 Million	-8,314 Reduced 63.66%	4,746 $1.27 Million
Q2 2022 Aug 22, 2022	SELL	$187.54 - $223.02 $64,888 - $77,164	-346 Reduced 2.58%	13,060 $2.66 Million
Q1 2022 May 19, 2022	BUY	$193.77 - $244.14 $73,826 - $93,017	381 Added 2.93%	13,406 $2.82 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $2.92 Million - $3.75 Million	13,025 New	13,025 $3.12 Million
Q4 2019 Jan 30, 2020	SELL	$220.06 - $304.07 $33,009 - $45,610	-150 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $32,506 - $50,844	150 New	150 $35,000
Q2 2018 Sep 04, 2018	SELL	$257.52 - $306.91 $8,755 - $10,434	-34 Closed	0 $0
Q1 2018 Jul 13, 2018	BUY	$260.13 - $367.91 $8,844 - $12,508	34 New	34 $9,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.